KATIE ELLIOTT: Open Payments
NPI 1649935503 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 52 payments from 17 companies in 2025. Trend: 2023 $915 · 2024 $847 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $129 |
| ABBVIE INC. | 3 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Novo Nordisk Inc | 4 | $72 |
| Exact Sciences Corporation | 4 | $65 |
| Amgen Inc. | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| PFIZER INC. | 2 | $42 |
Products named: AIRSUPRA, CAPLYTA, VRAYLAR, Kerendia, Ozempic, XIFAXAN, FANAPT, FARXIGA.
Industry payments across AL — which companies pay providers there.
